Immatics (IMTX) Debt Ratio (2020 - 2022)

Immatics (IMTX) reported Debt Ratio of 0.06 for Q3 2022, down 57.27% on a YoY basis from 0.13 in Q3 2021, and up 47.15% sequentially from 0.04 in Q2 2022.

Immatics (IMTX) Debt Ratio (2020 - 2022) Analysis & Trends

Immatics (IMTX) has 3 years of Debt Ratio data on file, last reported at 0.06 in Q3 2022.

  • For the quarter ending Q3 2022, Debt Ratio fell 57.27% year-over-year to 0.06; the trailing twelve-month figure through Sep 2022 stood at 0.06 (down 57.27% YoY), and the FY2021 full-year result was 0.16, up 140.8% from the prior year.
  • Debt Ratio improved to 0.06 in Q3 2022, from 0.04 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.16 in Q4 2021 to a low of 0.04 in Q2 2022.
  • A 3-year average of 0.08 and a median of 0.07 in 2020 frame the typical range for Debt Ratio.
  • Across the five-year window, Debt Ratio soared 140.8% in 2021 and slumped 60.11% in 2022, its largest moves.
  • Tracing IMTX's Debt Ratio over 3 years: stood at 0.07 in 2020, then soared by 140.8% to 0.16 in 2021, then plunged by 64.64% to 0.06 in 2022.
  • Business Quant data shows IMTX's Debt Ratio at 0.06 in Q3 2022, 0.04 in Q2 2022, and 0.04 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 0.06
Jun 30, 2022 0.04
Mar 31, 2022 0.04
Dec 31, 2021 0.16
Sep 30, 2021 0.13
Jun 30, 2021 0.10
Mar 31, 2021 0.08
Dec 31, 2020 0.07